Champions Oncology Inc
NASDAQ:CSBR
Wall Street
Price Targets
CSBR Price Targets Summary
Champions Oncology Inc
According to Wall Street analysts, the average 1-year price target for
CSBR
is 12.24 USD
with a low forecast of 12.12 USD and a high forecast of 12.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CSBR's stock price target?
Price Target
12.24
USD
According to Wall Street analysts, the average 1-year price target for
CSBR
is 12.24 USD
with a low forecast of 12.12 USD and a high forecast of 12.6 USD.
What is Champions Oncology Inc's Revenue forecast?
Projected CAGR
19%
For the last 13 years the
compound annual growth rate for
Champions Oncology Inc's revenue is
17%.
The projected
CAGR
for the next 3 years is
19%.
What is Champions Oncology Inc's Operating Income forecast?
Projected CAGR
26%
The
compound annual growth rate
of Champions Oncology Inc's operating income for the next 3 years is
26%.
What is Champions Oncology Inc's Net Income forecast?
Projected CAGR
-45%
The
compound annual growth rate
of Champions Oncology Inc's net income for the next 2 years is
-45%.
